Healthpeak Properties (NYSE:PEAK) Releases FY23 Earnings Guidance

compared to the Thomson Reuters consensus earnings per share estimate of $1.71. The company issued revenue guidance of $2.19-2.23 billion, compared to the consensus revenue estimate of $2.22 billion. Healthpeak Properties raises FY23 earnings guidance to $1.70-1.76 per share, above the $1.71 anal

() updated its FY23 earning guidance on Thursday morning. The company gave a guidance range of $1.70-1.76 per share for the period compared to the consensus estimate of $1.74.

Analyst Ratings Changes

PEAK was the subject of numerous research reports. Citigroup downgraded shares of Healthpeak Properties to a neutral ranking and set a price target for the company at $23.00. In a report published on Wednesday, 5th April. Jefferies Financial Group upgraded Healthpeak Properties shares from a Hold rating to a Buy rating and increased their price target for the stock in a report published on Monday, January 2. Morgan Stanley raised their price target on shares of Healthpeak Properties to $25.00 in a report published on Friday, 10th March. The stock was also given an equal weight rating. Mizuho upgraded shares of Healthpeak Properties to a Buy rating in a Monday research report. They also reduced the target price from $29.00 down to $25.00. Wells Fargo & Company began covering Healthpeak Properties shares in a research report on Wednesday, April 19. The company was given an equal-weight rating with a price target of $23.00. Seven analysts have given the stock a "hold" rating, and five others have given it a "buy" rating. Trading on Thursday saw a $0.44 increase, bringing the stock price to $21.21. The company's shares changed hands 5,960,711 times, as compared to the average of 4,410.849. Healthpeak Properties's 1 year low is $20.21, and its 1 year high is $34.35. The company has a simple moving 50-day average of $22.31 as well as a simple moving 200-day average of $25.24. The debt-to equity ratio for the company is 0.90. Its current ratio is 0.72, and its quick ratio 0.72. The stock's market capitalization is $11.60 billion. It has a P/E of 22.77 and a PEG of 3.11.

The company announced $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.43 by ($0.42). The company's $0.01 per share earnings for the quarter fell short of analysts' expectations ($0.42), which were $0.43. Revenue for the quarter was $524.47m, which is higher than the $518.85m consensus estimate. Healthpeak Properties' return on equity was 6.96%, and its net margin was 24.18%. Revenue was up by 8.5% from the same quarter of last year. In the same quarter of the previous year, the company earned $0.41 per share. Analysts expect Healthpeak Properties to post 1.73 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

A quarterly dividend was also declared by the company and paid out on Thursday, 23rd February. The dividend was paid to stockholders who were in the books on Thursday, February 9. The ex-dividend day was Wednesday, 8th February. The dividend yield is 5.66%. This dividend represents an annualized $1.20 and a dividend of $1.20. Healthpeak Properties has a dividend payout ratio of 130.44%.

Insider Buying & Selling

Thomas Klaritch, the COO of Healthpeak Properties, acquired 1,517 shares in a deal that took place on Tuesday, 7th March. The shares were bought at an average of $23.21 per stock, for a transaction totaling $35,209.57. The chief operating officer owns directly 344,000 shares worth $7,984,240. Scott M. Brinker, the CEO of Healthpeak Properties, purchased 16,300 shares in a deal on Thursday, 2nd March. The shares were purchased at a cost of $23.63 on average per share for a transaction totaling $385,169.00. The chief executive now owns 206 525 shares worth $4 880 185.75. Thomas Klaritch, the COO, also purchased 1,517 shares in the company's stock on Tuesday, 7th March. The stock was purchased at a price of $23.21 on average per share for a transaction totaling $35,209.57. After the completion of this transaction, the chief executive officer owns directly 344,000 shares in the company, valued at $7,984,240. In the past 90 days, insiders purchased 21,817 shares worth $506,099 of stock. Insiders hold 0.19% the stock of their company.

Inflows of Institutional Capital and Outflows

Recently, several institutional investors increased or decreased their stakes. Northwestern Mutual Wealth Management Co. grew its stake in Healthpeak Properties shares by 10.1% during the fourth quarter. Northwestern Mutual Wealth Management Co. owns 17,655 of the company’s shares worth $443,000, after buying an additional 1,624 in the fourth quarter. Alliancebernstein L.P. increased its stake in Healthpeak Properties during the fourth-quarter by 17.6%. Alliancebernstein L.P. owns now 1,341,277 of the company’s stock valued $33,626,000, after purchasing an additional 201.220 shares during the last quarter. Point72 Middle East FZE acquired a new investment in Healthpeak Properties valued at $2.629,000 during the fourth-quarter. Probity Advisors Inc. bought a new Healthpeak Properties position during the fourth-quarter valued at $235,000. State of Wyoming increased its holdings in Healthpeak Properties during the fourth-quarter by 133.1%. State of Wyoming owns 8 326 shares of stock in the company valued at $209,000, after buying an additional 4,754 during the last quarter. Institutional investors own 92.04% the company's stock.

Healthpeak Properties Company profile

Get Rating

Healthpeak Properties, Inc. is a real-estate investment trust that specializes in the acquisition, management, and ownership of healthcare real estate. It has three business segments: Life Science (biotechnology), Medical Office, and Continuing Care Retirement Community. The Life Science segment consists of laboratory and office spaces primarily for pharmaceutical, biotechnology and medical device companies, as well as government agencies and other organizations in the industry. offers a FREE daily email newsletter